Remove 2019 Remove Clinical Practice Remove IT Remove Management
article thumbnail

Episode 148: Antiracism in Medicine Series Episode 4 – Dismantling Race-Based Medicine Part 2: Clinical Perspectives

The Clinical Problem Solvers

Nwamaka Eneanya and Jennifer Tsai to discuss the limitations and harms of race-based medicine in clinical practice. Our guests explain how we can incorporate race-conscious medicine in clinical settings, medical education, and biomedical/epidemiological research to responsibly recognize and address the harms of racial inequality.

Clinic 52
article thumbnail

Are your patients satisfied?

Physician's Practice

Dr. Baum is Professor of Clinical Urology at Tulane Medical School in New Orleans, Louisiana. Dr. Baum is the author of Marketing Your Clinical Practice-Ethically, Effectively, and Economicall y, which is in its 4th edition, has sold over 175,000 copies and has been translated into Spanish. About Neil Baum, M.D.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

You don’t need to order comprehensive viral panels for most patients

PEMBlog

Identifying the specific type of virus that are causing a child’s symptoms, like rhinovirus vs parainfluenza, is often unnecessary, especially in otherwise healthy children who are managed at home. Comprehensive respiratory viral panels (i.e., Reasons to not order a comprehensive respiratory viral panel (i.e., for bronchiolitis and 1.5%

article thumbnail

The Incredible Shrinking Exemption: FDA Final CDS Guidance Would Significantly Narrow the Scope of Exempt Clinical Decision Support Software Under the Cures Act

FDA Law

Javitt — On September 28, 2022, the FDA issued the long anticipated final Clinical Decision Support Software Guidance (CDS Guidance), which replaces the revised draft guidance document from 2019. Interpretation of Statutory Criteria Under the Final Guidance. Medical information about a patient.

Clinic 52
article thumbnail

PC for Patients with Substance Use Disorder: Janet Ho, Sach Kale, Julie Childers

GeriPal

Substance use disorder is one of those complex issues in which clinical practice is changing rapidly. What is harm reduction and how can we implement it in practice? Summary Transcript CME Summary Much like deprescribing , we plan to revisit certain high impact and dynamic topics frequently. Eric 00:58 Substance use disorder.

article thumbnail

The importance of social connection: Julianne Holt-Lunstad, Thomas Cudjoe, & Carla Perissinotto

GeriPal

Summary Transcript Summary Social connections impact our health in profound ways, whether it is the support we receive from family and friends in navigating serious illness, the joy from shared social activities, or connecting with our community. Welcome back, Ashwin. Ashwin Kotwal: Excited to be back. Eric: Now, it’s interesting. Alex: Great.

IT 99
article thumbnail

Do statins reduce mortality in older people? Findings from a longitudinal study using primary care records

BMJ

This is because clinical trials are expensive to carry out and therefore tend to be of relatively short duration, with statins trials having on average two to five years of treatment exposure. In clinical practice, patients are not fixed on a certain treatment regime and can start and stop at any time.